Invivyd

3D rendering of SARS-CoV-2 virus particles

Invivyd says Pemgarda sequel could be alternative to COVID shots

Invivyd has touted its follow-up to the FDA-authorized monoclonal antibody Pemgarda as potentially offering better protection than available vaccines.

James Waldron Jun 26, 2025 10:12am

Invivyd, FDA agree on steps to EUA for COVID monoclonal antibody

Jun 26, 2023 10:36am

change direction new plan alter arrows move reprioritize

Invivyd evolves yet again to keep pace with COVID-19

Mar 6, 2023 10:45am

Invivyd faces C-suite departures, commercial layoffs

Oct 14, 2022 10:29am